Prajwal Salins

Mr. Prajwal Salins


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 March 2023 in Sustainability
Verified
Journal Article
Open access
PDF file
RKRajesh Kamath
Rajesh Kamath
HBHelmut Brand
Helmut Brand
NNNisha Nayak
Nisha Nayak
VRVani Lakshmi R
Vani Lakshmi R
RVReena Verma
Reena Verma
PSPrajwal Salins
Prajwal Salins
Reducing catastrophic out-of-pocket expenditure (OOPE) and increasing the rates of institutional deliveries are part of the Sustainable Development Goals (SDGs). India has made significant progress on the maternal and child health front in recent years. India’s National Health Mission (NHM) has been able to increase rates of institutional deliveries. In the present study, we aim to ascertain district-level patterns of percentage of health insurance coverage in the National Family Health Surveys NFHS 4 and NFHS 5. We also aim to ascertain district-level patterns of out-of-pocket expenditure on C-section deliveries in public health facilities in NFHS 4 and NFHS 5. The present study explores district-level data associated with health insurance coverage (%) and out-of-pocket expenditure in a public health facility (in INR) observed across NFHS 4 and NFHS 5. A spatial analysis was carried out using QGIS 3.26 (Mac version) and GeoDA 1.20.0.8. A visual assessment of the maps across NFHS 4 and NFHS 5 shows improvement in insurance coverage at the district level across the two surveys. Despite an increase in insurance coverage, North East India has experienced an increase in OOPE for C-section deliveries. Rajasthan and various parts of South India have experienced a decrease in OOPE for C-section deliveries. Kerala has experienced a rise in insurance coverage and OOPE for C-section deliveries. Univariate LISA cluster and significance maps revealed that Kerala and Tamil Nadu, the eastern coast of India and parts of Mizoram are hot spots, whereas Jammu and Kashmir and parts of Uttar Pradesh and Gujarat are cold spots. Both these findings are significant. Rajasthan emerges as a significant hot spot along with parts of Assam and a few districts on the eastern coast of India in Tamil Nadu and Andhra Pradesh. Jammu and Kashmir, Ladakh, parts of Uttar Pradesh, Maharashtra, and Karnataka have emerged as significant cold spots. The South Indian states of Kerala and Tamil Nadu are no longer hot spots indicating geospatial variations across time. An increase in the number of hot spots across NFHS 4 and NFHS 5 indicates rising out-of-pocket expenditure for C-sections despite growth in health insurance coverage. The present study does not offer any evidence to suggest that health insurance coverage decreases OOPE on C-section deliveries at government facilities. With RSBY having been launched in 2008 and Ayushman Bharat in 2018, high levels of OOPE on C-section deliveries at government facilities raise serious concerns about the efficacy of PFHIs in reducing OOPE. The government would need to plug the well-documented weaknesses of PFHIs, such as fraud, double charging, poor enrolment, and lack of awareness in addition to the unfortunate phenomena of “tips” and “tie ups” mentioned earlier that plague the public healthcare system, if we are to see any reduction in OOPE in the foreseeable future.

RKRajesh Kamath
Rajesh Kamath
CSChris Sebastian
Chris Sebastian
VJVarshini R J
Varshini R J
SASiddhartha Sankar Acharya
Siddhartha Sankar Acharya
AKAshok Kamat
Ashok Kamat
SBSanjay Kini B
Sanjay Kini B
Out-of-pocket expenditure (OOPE) comprises 62% of national health expenditure in India. This heavy reliance on direct payments has engendered economic vulnerability and catastrophic financial pressures (typically defined as out-of-pocket spending exceeding a certain threshold of household income, leading to financial hardship) on households in a country where public health spending remains below targeted levels. The onset of the COVID-19 pandemic intensified these financial hardships further, as both total healthcare spending and OOPE experienced significant escalations due to the increased need for emergency care, vaccination efforts, and expanded health infrastructure. A retrospective, single-center study was conducted using data from COVID-19 patients admitted between June 2020 and June 2022. Patient data were collected from the Medical Records, IT, and Finance departments. A validated proforma was used for data extraction. Descriptive statistics were calculated, and the Shapiro–Wilk test was applied to assess normality of billing and OOPE data. Patients were stratified into three groups based on their insurance status, allowing for comparative analysis of OOPE percentages and absolute expenditures. The 2715 COVID-19 patients were categorized into three groups according to their health financing: those covered under AB-PMJAY (42.76%), private health insurance (22.16%), and the uninsured (35%). While the median billing amounts were comparable across these groups (ranging between INR 85,000 and INR 90,000), a substantial disparity was observed in terms of financial burden. All patients covered under AB-PMJAY incurred no OOPE, whereas privately insured patients had a median OOPE that constituted approximately 21% of their total billing amounts, with significant variability among different insurers. The uninsured group represented 35% of the cases and experienced the highest median OOPE, indicating substantial financial risk. The COVID-19 pandemic has revealed critical gaps in India’s health financing framework. This study emphasizes the strong financial protection provided by AB-PMJAY, while also exposing the limitations of private health insurance in shielding patients from substantial healthcare costs. As the country progresses toward universal health coverage, there is a pressing need to expand public health insurance schemes that are inclusive, equitable, and effectively implemented. Additionally, strengthening regulation and accountability in the private insurance sector is essential. The study findings reinforce that AB-PMJAY has been highly successful in reducing OOPE and enhancing financial risk protection. Although private insurance reduced OOPE, patients still faced considerable expenses. The stark difference in OOPE of 100% for uninsured patients, 21.16% for privately insured, and 0% for AB-PMJAY beneficiaries underscores the importance of further expanding AB-PMJAY to reach more vulnerable populations.

28 January 2025 in F1000Research
Verified
Journal Article
Open access
PDF file
SKSagarika Kamath
Sagarika Kamath
SASiddhartha Sankar Acharya
Siddhartha Sankar Acharya
HBHelmut Brand
Helmut Brand
PSPrajwal Salins
Prajwal Salins
RVReena Verma
Reena Verma
RKRajesh Kamath
Rajesh Kamath
Introduction OOPE for healthcare services is a major concern within the Indian healthcare system. 30% of the population remains uninsured despite increasing health insurance coverage. For obstetrics and gynaecology (OBG) patients financial obstacles like OOPE can delay access to health care, evaluating spending patterns can inform policies to enhance accessibility, affordability and equitable health. Methodology A retrospective study was conducted at a tertiary care teaching hospital in Karnataka state of India to analyze OOPE for 905 OBG patients who underwent Cesarean Section(C-Section), Laparoscopic Hysterectomy, Laparoscopic Cystectomy, Laparoscopic Myomectomy and Laparoscopic Assisted Vaginal Hysterectomy (LAVH). These were the top five most performed obstetrics and gynecology surgeries in the tertiary care teaching hospital between January 2023 and July 2023. Data was collected across AB-PMJAY, private health insurance, uninsured patients and analyzed using descriptive statistics (mean, median) and the Shapiro-Wilk test for data normality. Results The study analyzed OOPE across 905 OBG patients. Findings show AB-PMJAY provided full coverage with zero OOPE for all surgeries. Though private health insurance reduced OOPE compared to uninsured patients under private health insurance still faced significant financial burden. Variations existed in minimum and maximum OOPE and percentage of OOPE across different private insurances. All the uninsured patients incurred 100% OOPE, with a median OOPE of Rs. 33,257 (405.67 USD) to Rs. 57,053 (695.76 USD) and a mean OOPE of Rs. 39,848 (485.95 USD) to Rs. 60,687 (740 USD) across the surgeries. Discussion Findings of the study show that AB-PMJAY is highly effective in reducing OOPE and enhancing financial risk protection for OBG patients. Patients covered by private health insurance incurred less OOPE, yet the burden remained considerable. High OOPE rates for uninsured patients (100%) and private health insurance (38.15%) compared to 0% OOPE in AB-PMJAY emphasizes the need for the continued expansion of AB-PMJAY.

18 July 2025 in F1000Research
Verified
Journal Article
Open access
PDF file
PSPrajwal Salins
Prajwal Salins
SNSuma Nair
Suma Nair
PKPoornima Panduranga Kundapur
Poornima Panduranga Kundapur
APAkhilesh K Pandey
Akhilesh K Pandey
RBReshmi Bhageerathy
Reshmi Bhageerathy
SMSabu K Mandapam
Sabu K Mandapam
Background Hypertension is a significant risk factor for cardiovascular disease, contributing to global mortality and disability. Approximately 30% of Indian adults are diagnosed with hypertension. Evidence supports that self-monitoring and blood pressure self-management can lower systolic BP by an average of 3.2 mmHg. mHealth applications facilitate remote monitoring and self-management, yet existing applications in India lack customisation for user needs, limiting their usability. This study aims to develop and evaluate a novel, user-friendly mHealth application tailored to hypertensive individuals. Methods This study follows an Agile development design, an iterative software development approach that allows continuous feedback and refinement. The research will be conducted in three phases over an anticipated duration of 48 months. Phase 1 (12 months) will involve in-depth interviews and focus group discussions to identify essential features for a customised Android-based mHealth application. Phase 2 (12 months) will involve developing the application using Android Studio following Agile principles. Phase 3 (18 months) will be a community-based cluster randomised trial conducted in 12 villages to evaluate the application’s effectiveness. Villages will be randomised into intervention and control groups. Each group will include 118 participants. The intervention group will use the mHealth application, while the control group will follow the standard hypertension management regimen. Villages and participants will be selected based on specific criteria, including population size, availability of healthcare facilities, and smartphone accessibility among hypertensive patients. Results In the proposed study, if the intervention is helpful, hypertension patients in the community can be encouraged to use the mHealth application. If found effective, this application is anticipated to improve hypertensive patients’ health status, knowledge, and self-care approach. Registration: Clinical Trials Registry - India ( CTRI/2022/03/041544 ).

17 July 2026 in F1000Research
Verified
Journal Article
Open access
PDF file
PSPrajwal Salins
Prajwal Salins
SMSabu K Mandapam
Sabu K Mandapam
RBReshmi Bhageerathy
Reshmi Bhageerathy
RKRaksha Kamath
Raksha Kamath
SNSuma Nair
Suma Nair
PKPoornima Panduranga Kundapur
Poornima Panduranga Kundapur
Background Given the significant global burden of hypertension and the perception of service quality significantly influences a patient’s satisfaction and their willingness to engage with mobile health (mHealth) interventions, this study aimed to develop and validate a Focus Group Discussion (FGD) guide to explore the self-management needs, preferences, and barriers of patients with hypertension for designing a contextually relevant mHealth application. Methods The FGD guide was developed via literature review and validated through a two-step process. First, face validity was assessed by a panel of five experts to evaluate flow, clarity, and comprehensiveness. Subsequently, content validity was quantified by a separate panel of ten experts using a structured assessment, with results analyzed via the Content Validity Index (CVI), Content Validity Ratio (CVR), and Kappa statistics. The guide was also pilot-tested with a small sample to refine clarity and depth before final use. Results Expert evaluations demonstrated high item-level content validity, with CVR and Kappa coefficient values ≥0.8 and ≥ 0.89, respectively. The S-CVI (universal agreement) indicated moderate content validity, while the S-CVI (average method) revealed high content validity. Feedback from both healthcare professionals and hypertensive patients resulted in improvements to wording, clarity, and contextual relevance, thereby enhancing the guide’s comprehensibility and cultural alignment. Conclusion This systematically developed FGD guide demonstrates moderate to high content validity and acceptable reliability. It is a suitable, validated tool for exploring patient-reported experiences in hypertension self-management to inform patient-centered mHealth interventions.

28 November 2022 in F1000Research
Verified
Journal Article
Open access
PDF file
PSPrajwal Salins
Prajwal Salins
SNSuma Nair
Suma Nair
PKPoornima Panduranga Kundapur
Poornima Panduranga Kundapur
APAkhilesh K Pandey
Akhilesh K Pandey
RBReshmi Bhageerathy
Reshmi Bhageerathy
SMSabu K Mandapam
Sabu K Mandapam
Background: Hypertension is the most important risk factor for cardiovascular disease, a major cause of death and disability globally. There is increasing evidence that demonstrates clinically relevant benefits from self-monitoring and self-management of blood pressure. Evidence suggests a reduction of systolic BP by 3.2 mm/hg through self-monitoring. The use of mHealth applications in health care monitoring and self-management can help in the timely delivery of health information. Around 33% of Indians use mHealth applications in their daily life. However, well-designed, user complied mHealth applications are essential to reach the masses and to be effective. A previously conducted study in India demonstrated that applications are not customized according to users' needs and expectations and lacked usability assessment by patients. Therefore, we aimed to develop and test a novel mHealth application on remote monitoring and self-management in hypertension. Methods: The study will be carried out in three phases. The first phase will be an in-depth interview to identify the required parameters to develop a customized mHealth android-based application to monitor hypertension. The second phase is to develop the customized application through the Agile development design using the android studio platform. In the third phase, a community-based cluster randomized trial will be carried out to assess the effectiveness of the mHealth intervention on the remote monitoring and self-management of people with hypertension. A sample of 236 people from 12 villages will be randomized and the mHealth application will be delivered to the intervention group and the standard regimen will be continued in the control group. Results: In the proposed study if the intervention is found to be helpful, then hypertension patients in the community can be encouraged to install the mHealth application. This application, if found effective can improve the health status, knowledge, and self-care approach among hypertensive patients. Registration: CTR India (CTRI/2022/03/041544).